What are the advantages of MDC EYESIS treating MGD with meibomian gland dysfunct

Meibomian gland dysfunction MGD is the most common cause of dry eye. It can lead to tear film changes, causing dryness, pain, burning sensation, foreign body sensation, blurred vision and other symptoms. Therefore, targeted treatment is required after diagnosis. The traditional treatment mainly focuses on anti-inflammatory or artificial tear supplement for ocular surface symptoms. Although it can relieve symptoms and control the development of the disease, the long-term clinical effect is still not ideal.

IPL is a hot frontier technology at present, which is an effective supplement to the traditional treatment of meibomian gland dysfunction MGD. The latest research of the Third Hospital of Peking University found that MDC EYESIS Eye Dry Eye Therapeutic Apparatus combined with meibomian gland massage MGX can significantly and effectively treat dry eye caused by MGD. Its mechanism is not only to inhibit abnormal blood vessel formation, liquefy meibomian gland secretion, reduce the expression of inflammatory mediators and light regulation, but also likely to be one of the mechanisms of the EYESIS Dry Eye Therapeutic Apparatus.

At present, a number of medical studies have shown that the indications of EYESIS intense pulsed light in ophthalmology are mainly to inhibit telangiectasia to reduce the vascularization of the eyelid margin, to liquefy the secretion of the tarsal gland to improve the microenvironment of the eye surface, to treat demodicid blepharitis and children's chalazion. At the same time, in order to facilitate the patient to have a visual understanding of the treatment process, we will make a schematic diagram of the five positions of the light spots emitted by the device.

Compared with other products, EYESIS dry eye therapeutic instrument has the advantage that it is a professional dry eye treatment equipment with ophthalmic indications. It uses the selective photothermal effect of intense pulsed light to treat dry eyes, and a single irradiation can stimulate up to 10 pulse clusters. It is easy to operate. It is safe to irradiate the lower eyelid of one side for five consecutive times, and the patient suffers less. Clinical research shows that after three times of treatment, dry eye signs can be improved, and eye discomfort symptoms such as dry and astringent eyes, eye pain, eye itching, foreign body sensation, photophobia, and increased secretion can be alleviated. After four or five times of treatment, the effect can be maintained for 1~2 years.